LRRK2 and Parkinson disease: Our data also demonstrated that the selection of a relatively homogeneous group of RNA samples from Ashkenazi women that do not carry either GBA or LRRK2 founder mutations [14,15] increased the ability to detect novel expression changes in PD patients' PBL.